MISSION Leadership and Members Research Meetings Patient Resources News Contact
What is APS?
How is APS Action Helping?
     
 

A Catalyst for Antiphospholipid
Syndrome Research

March 2011 - The treatment of the serious, potentially fatal autoimmune clotting disorder antiphospholipid syndrome (APS) has, in general, been empiric and based on various approaches to inhibit the clotting system.
Read More



Little-Studied Blood Syndrome Gains
Researchers' Attention

March 15, 2011 - Motivated by the lack of treatment options for patients with antiphospholipid syndrome (APS), rheumatology researchers convened an international committee to address the problem directly. Read More


International Summit Held
to Stimulate Collaborative Clinical Research on Antiphospholipid Syndrome

November 2, 2010 - Antiphospholipid Syndrome (APS) is a condition that may be responsible for up to one-third of strokes in people under age 50, up to one-fifth of all cases of blood clots in large veins, and one-quarter of recurrent miscarriages. Read More

International Network to Launch Clinical Trials Worldwide

Antiphospholipid Syndrome is a life-threatening autoimmune disorder in which your immune system mistakenly produces antibodies against certain normal proteins in your blood – causing blood clots within your arteries or veins as well as pregnancy complications, such as miscarriages and stillbirths. Please click here to learn more about APS.

It is a leading cause of stroke in young people, responsible for 1 out of 3 strokes in people under 50, 1 out of 5 recurrent miscarriages, and up to 20% of all deep-vein blood clots (DVT).

APS Action is a network of internationally renown physicians and scientists that works to find a cure for Antiphospholopid Syndrome. Members of the steering committee for APS Action include:


Laura Andreoli

University of Brescia,
Brescia, Italy

Ware Branch

University of Utah School of
Medicine, Salt Lake City, UT, USA

Ricard Cervera

Hospital Clinic, Barcelona,
Catalonia, Spain

Hannah Cohen

University College London
Hospitals, London, UK

Maria Cuadrado

St. Thomas Hospital,
London, England

Philip deGroot

University Medical Centre,
Utrecht, Netherlands

Ronald Derksen

University Medical Centre,
Utrecht, Netherlands

Doruk Erkan

Hospital for Special Surgery,
New York, NY, USA

Paul Fortin

Centre Hospitalier Universitaire
de Quebec, Quebec, Canada

 

Bill Giannakopoulos

St. George Hospital, University
of New South Wales,
Sydney, Australia

Munther Khamashta

St. Thomas Hospital,
London, England

Steve Krilis

St. George Hospital, University
of New South Wales,
Sydney, Australia

Steven R. Levine

SUNY Health Science Center, Downstate Stroke Center,
Brooklyn, NY, USA

Roger Levy

Universidade do Estado do
Rio de Janeiro, Brazil

Michael Lockshin

Hospital for Special Surgery,
New York, NY, USA

Pierluigi Meroni

University of Milan,
Milan, Italy

Tom Ortel

Duke University Medical Center,
Durham, NC, USA

Vittorio Pengo

University Hospital,
Padova, Italy

Silvia Pierangeli

University of Texas Medical Branch, Galveston, Texas, USA

Guillermo Pons-Estel

Hospital Clínic, Barcelona,
Catalonia, Spain

Jacob Rand

Montefiore Medical Center,
Bronx, NY, USA

Robert Roubey

University of North Carolina,
Chapel Hill, NC, USA

Jane Salmon

Hospital for Special Surgery,
New York, NY, USA

Angela Tincani

University of Brescia,
Brescia, Italy

Denis Wahl

Nancy University,
Nancy, France